World’s First Wearable Device to Measure Neonatal Jaundice and Vitals
Written by AZoSensorsMar 5 2021
Japanese scientists have designed the first-ever wearable devices to accurately monitor jaundice, a yellowing of the skin due to increased bilirubin levels in the blood that can result in severe medical conditions in infants.
Schematic of neonatal wearable device for detecting jaundice and vitals. Image Credit: Yokohama National University.
Treatment for jaundice can be done effortlessly by irradiating the infant with a blue light that disintegrates bilirubin, which is later secreted via urine. But the treatment itself can disturb bonding time, lead to dehydration and elevate the risks of allergic diseases.
Credit: Yokohama National University
Researchers in Japan have developed the first wearable devices to precisely monitor jaundice, a yellowing of the skin caused by elevated bilirubin levels in the blood that can cause severe medical conditions in newborns. Jaundice can be treated easily by irradiating the infant with blue light that breaks bilirubin down to be excreted through urine. The treatment itself, however, can disrupt bonding time, cause dehydration and increase the risks of allergic diseases. Neonatal jaundice is one of the leading causes of death and brain damage in infants in low- and middle-income countries.
To address the tricky balance of administering the precise amount of blue light needed to counteract the exact levels of bilirubin, researchers have developed the first wearable sensor for newborns that is capable of continuously measuring bilirubin. In addition to bilirubin detection, the device can simultaneously detect pulse rate and blood oxygen saturation in
E-Mail
The International Society for Stem Cell Research (ISSCR) launches a new scientific series today, Stem Cells and Global Sustainability, which explores the intersection of stem cell science and global sustainability issues. The four-part series is sponsored by Burroughs Wellcome Fund, BioLamina, NH Foods, and Olympus. Learn more and register. I am delighted that the ISSCR is shining a light on efforts in the stem cell research community to address biodiversity and sustainability issues, said Steve Kattman, Sana Biotechnologies, and a co-organizer of the program with Takanori Takabe, MD, PhD, Cincinnati Children s Hospital Medical Center, USA and Tokyo Medical and Dental University, Japan. The digital series, Stem Cells and Global Sustainability, brings together stem cell researchers, conservation biologists, global ecologists, and food industry innovators to discuss these critical global challenges and ways that Stem Cell Research could have an impact.
A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS) are the main causative factors for alveolar barrier disruption. In COVID-19 patients with ARDS, endothelial injury persists for a longer time than epithelial injury.
E-Mail
Skokie, IL - The ISSCR is bringing together successful biotech CEOs who have transformed scientific breakthroughs into thriving businesses that are improving human health into one program 7-8 January 2021.
VISION2030 comes at a pivotal moment in regenerative medicine and stem cell science as discovery, translation, and investment intersect.
Thursday, 7 January
STEMCELL Technologies Executive Interview
Interviewed by ISSCR Board Member Valentina Greco, Yale University School of Medicine, USA
STEMCELL Technologies mission is to advance the pursuit of scientific knowledge by supplying high quality, innovative reagents, tools, and services that enable life science research.
Surrozen Executive Interview
Claudia Janda, Princes Máxima Centrum, Netherlands l Surrozen Founder